This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo
News

Percentage of Cancers in England Diagnosed at Stage I or II

In England in 2018, 55% of cancers diagnosed and recorded as stage I-IV were recorded as stages I and II, ranging from 48% in some Clinical Commissioning Groups (CCGs) to 64% in others. The figures, released by Public Health England (PHE), are comparable to the previous year (2017) when the unadjusted percentage was 54%, ranging from 47% to 60%.

The percentage of cancers diagnosed at stages I and II varied by cancer site and ranged from 13.5% of cancers of the oropharynx, base of tongue, tonsil, soft palate and uvula to 92.0% of testicular cancers.

More than 75% of the following cancers were diagnosed at stage I or II: melanoma (89.2%), thyroid (88.9%), breast (85.8%), uterus (80.8%), cervix (80.3%) and bladder (75.8%).

The percentages for renal (except renal pelvis), prostate, and the laryngeal cancers (including anterior surface of the epiglottis) were 56.9%, 54.6%, and 50.9%, respectively.

Of cancers of the oral cavity, hard palate and lip (inner aspect), 46.5% were diagnosed at stage I or II, similar to percentages for Hodgkin lymphoma (45.2%) and cancer of the colon (45.0%) and the rectum and rectosigmoid junction (43.0%). Forty per cent of cancer of the ovary or fallopian tube and primary peritoneal carcinomas were diagnosed at stage I or II. This dropped to 30% for non-Hodgkin lymphoma.

Percentages fell to below 30 for cancers of the lung (28.9%), stomach excluding cardia and gastroesophageal junction (27.4%), pancreas (22.6%), and the oesophagus including cardia and gastroesophageal junction (21.5%).

The data suggest there is a need for greater awareness of the early symptoms and signs of some common cancers.

National Disease Registration Service: Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, by Clinical Commissioning Group. Public Health England. 2020 May 29

This article originally appeared on Univadis, part of the Medscape Professional Network.

YOU MAY ALSO LIKE